Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04250545 |
|---|---|
| Brief Title: | Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer |
| First Submitted : | January 30, 2020 |
| First Submitted that Met QC Criteria : | January 30, 2020 |
| First Posted : | January 31, 2020 |
| Last Update Submitted that Met QC Criteria : | March 8, 2024 |
| Last Update Posted : | March 12, 2024 |